Quick Answer
Bausch Health Companies Inc. reported Revenue (ASC 606) of $10.27 billion for fiscal year 2025.
Bausch Health Companies Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $10.27B | +6.7% |
| 2024 | $9.62B | +9.9% |
| 2023 | $8.76B | +7.8% |
| 2022 | $8.12B | -3.7% |
| 2021 | $8.43B | +5.1% |
| 2020 | $8.03B | -6.7% |
| 2019 | $8.60B | +2.6% |
| 2018 | $8.38B | -3.9% |
| 2017 | $8.72B | -9.8% |
| 2016 | $9.67B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.68B | +6.8% | +6.0% |
| June 30, 2025 | $2.53B | +5.3% | +12.0% |
| March 31, 2025 | $2.26B | +4.9% | -10.0% |
| September 30, 2024 | $2.51B | +12.2% | +4.5% |
| June 30, 2024 | $2.40B | +10.9% | +11.6% |
| March 31, 2024 | $2.15B | +10.8% | -3.8% |
| September 30, 2023 | $2.24B | +9.4% | +3.3% |
| June 30, 2023 | $2.17B | +10.2% | +11.5% |
- Bausch Health Companies Inc. showed an increase of +6.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, Bausch Health Companies Inc.’s revenue (asc 606) has grown by 6.1% (from $9.67 billion to $10.27 billion).
- The most recent figure is from Bausch Health Companies Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: